Omeprazole Noridem (Omeprazole Sodium)

Omeprazole Sodium, the active ingredient in Omeprazole Noridem, is a proton pump inhibitor presented as a tablet for oral use. It reduces stomach acid production and is used to treat acid‑related disorders in adults and children. GNH USA supplies Omeprazole Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omeprazole Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole Noridem is a proton‑pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related conditions: - Gastro‑esophageal reflux disease (GERD): provides symptomatic relief and promotes healing of erosive esophagitis. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls gastric acid hypersecretion. - Helicobacter pylori eradication regimens: used as adjunct therapy to improve eradication rates. - NSAID‑associated ulcer prevention: lowers risk of ulcer development in high‑risk patients.

Adverse reactions to Omeprazole Noridem are generally mild to moderate and vary in frequency.

Common Side Effects: - Headache: mild, transient headache. - Diarrhoea: loose stools, often self‑limiting. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the stomach area. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis, requires medical attention. - Acute interstitial nephritis: sudden kidney inflammation. - Hypomagnesemia: low magnesium levels, may cause muscle cramps. - Stevens‑Johnson syndrome: rare severe skin reaction. - Hepatic dysfunction: elevated liver enzymes. - Fracture risk: possible reduction in bone mineral density with long‑term use.

When using Omeprazole Noridem, consider the following precautions: - Assess renal function: adjust use in severe renal impairment. - Evaluate hepatic status: use with caution in liver disease. - Review long‑term therapy: monitor for bone density loss. - Pregnancy and lactation: weigh benefits against potential risks. - Drug interactions: check concomitant medications for possible interactions. - Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Omeprazole Noridem can affect the plasma concentrations of several co‑administered drugs.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, may increase cardiovascular risk. - Atorvastatin: increased statin exposure, higher risk of myopathy. - Methotrexate: elevated levels, potential toxicity.

Moderate Interactions (Monitor Closely): - Warfarin: possible alteration of INR, monitor coagulation. - Digoxin: modest increase in serum concentration. - Diazepam: enhanced sedation, observe CNS effects.